124 related articles for article (PubMed ID: 3202908)
1. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.
Harris BE; Song RL; He YJ; Soong SJ; Diasio RB
Biochem Pharmacol; 1988 Dec; 37(24):4759-62. PubMed ID: 3202908
[TBL] [Abstract][Full Text] [Related]
2. Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.
Harris BE; Song RL; Soong SJ; Diasio RB
Cancer Res; 1989 Dec; 49(23):6610-4. PubMed ID: 2819711
[TBL] [Abstract][Full Text] [Related]
3. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.
Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
Cancer Res; 1993 Jun; 53(12):2816-22. PubMed ID: 8504424
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines.
Naguib FN; Soong SJ; el Kouni MH
Biochem Pharmacol; 1993 Feb; 45(3):667-73. PubMed ID: 8442766
[TBL] [Abstract][Full Text] [Related]
5. Circadian rhythm of rat spleen cytoplasmic thymidine kinase.
Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
Biochem Pharmacol; 1993 Mar; 45(5):1115-9. PubMed ID: 8461041
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression.
Porsin B; Formento JL; Filipski E; Etienne MC; Francoual M; Renée N; Magné N; Lévi F; Milano G
Eur J Cancer; 2003 Apr; 39(6):822-8. PubMed ID: 12651209
[TBL] [Abstract][Full Text] [Related]
7. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.
Harris BE; Song R; Soong SJ; Diasio RB
Cancer Res; 1990 Jan; 50(1):197-201. PubMed ID: 2293556
[TBL] [Abstract][Full Text] [Related]
8. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
Raida M; Kliche KO; Schwabe W; Häusler P; Clement JH; Behnke D; Höffken K
J Cancer Res Clin Oncol; 2002 Feb; 128(2):96-102. PubMed ID: 11862480
[TBL] [Abstract][Full Text] [Related]
9. Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells.
Grem JL; Yee LK; Venzon DJ; Takimoto CH; Allegra CJ
Cancer Chemother Pharmacol; 1997; 40(2):117-25. PubMed ID: 9182832
[TBL] [Abstract][Full Text] [Related]
10. CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.
Shimizu M; Tamura T; Yamada Y; Akiyama Y; Saijo N; Nishio K
Jpn J Cancer Res; 2001 May; 92(5):554-61. PubMed ID: 11376565
[TBL] [Abstract][Full Text] [Related]
11. Liver dihydropyrimidine dehydrogenase activity in human, cynomolgus monkey, rhesus monkey, dog, rat and mouse.
Sludden J; Hardy SC; VandenBranden MR; Wrighton SA; McLeod HL
Pharmacology; 1998 May; 56(5):276-80. PubMed ID: 9597696
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythm of hepatic uridine phosphorylase activity and plasma concentration of uridine in mice.
el Kouni MH; Naguib FN; Park KS; Cha S; Darnowski JW; Soong SJ
Biochem Pharmacol; 1990 Dec; 40(11):2479-85. PubMed ID: 2148479
[TBL] [Abstract][Full Text] [Related]
13. Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.
Jiang H; Lu J; Ji J
Br J Pharmacol; 2004 Feb; 141(4):616-23. PubMed ID: 14744810
[TBL] [Abstract][Full Text] [Related]
14. [Dihydropyrimidine deshydrogenase (DPD): rhythm and consequences].
Barrat-Petit MA; Naulin-Ifi C; Mahler P; Milano G
Pathol Biol (Paris); 2005 Jun; 53(5):261-4. PubMed ID: 15939134
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy.
Lu Z; Zhang R; Diasio RB
Cancer Res; 1993 Nov; 53(22):5433-8. PubMed ID: 8221682
[TBL] [Abstract][Full Text] [Related]
16. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.
Jiang W; Lu Z; He Y; Diasio RB
Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyrimidine dehydrogenase activity in human pancreatic tumor tissues.
Nagakawa T; Kayahara M; Ohta T; Kitagawa H; Mikami K; Kurata T; Otsuji S
Cancer Invest; 2000; 18(6):516-20. PubMed ID: 10923099
[TBL] [Abstract][Full Text] [Related]
19. Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy.
Lu Z; Zhang R; Diasio RB
Clin Pharmacol Ther; 1995 Nov; 58(5):512-22. PubMed ID: 7586945
[TBL] [Abstract][Full Text] [Related]
20. Circadian expression of dihydropyrimidine dehydrogenase, thymidylate synthase, c-myc and p53 mRNA in mouse liver tissue.
Wu MW; Xian LJ; Li XM; Pasquale I; Francis L
Ai Zheng; 2004 Mar; 23(3):235-42. PubMed ID: 15025949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
